(date) FILE
NUMBER:

NAME
OF EMPLOYEE:

(Claimant name)

(Claimant address)

(Claimant address)

Dear:

Our records indicate that you
have a claim for compensation under the Energy Employees Occupational Illness
Compensation Program Act that received a dose reconstruction from the National
Institute for Occupational Safety and Health (NIOSH).

I am writing to inform you
that on August 7, 2007, NIOSH issued OCAS-PER-012 entitled, “Evaluation of
Highly Insoluble Plutonium Compounds.” The changes identified in the report
affect the dose reconstruction methodology by which a dose reconstruction is
conducted. This change went into effect on February 6, 2007.

The Division of Energy
Employees Occupational Illness Compensation is obligated to ensure that the
application of the dose reconstruction methodology is administered in a fair
and consistent manner. As a result of the changes made by NIOSH, the prior
dose reconstruction and percentage used to establish the compensability on your
claim may be invalid. While the modification to the dose reconstruction
methodology may not impact the outcome of your claim, it is necessary for your
claim to undergo a new dose reconstruction in order to make that
determination. Accordingly, I am returning your case to NIOSH.

Once the revised dose
reconstruction is complete, you will have
the opportunity to review the dose reconstruction report, and will again be
required by NIOSH to sign the OCAS-1 to acknowledge your receipt of the revised
report and dose reconstruction results.

I will then use the
information from the revised dose reconstruction to recalculate the percentage
to determine whether the claimed cancer(s) was at least as likely as not (50%
or greater) related to the covered employment.

Again
the change indicated above does not mean that your claim will be approved; it
simply requires that your dose reconstruction be redone using the new guidance.
NIOSH will inform you of the results of that new dose reconstruction, and a new
decision will be issued on your claim, using the new dose reconstruction.

If
you have specific questions regarding the status of the dose reconstruction, you may contact the NIOSH office located in
Cincinnati, Ohio at (513)
533-6800 or (513) 533-8423. Any other questions should still be addressed to
this office.